scholarly journals Ecdysteroidogenesis in Heliothis virescens (Lepidoptera: Noctuidae): Recombinant Prothoracicotropic Hormone and Brain Extract Show Comparable Effects

2019 ◽  
Vol 19 (3) ◽  
Author(s):  
Marisa Nardiello ◽  
Rosanna Salvia ◽  
Andrea Scala ◽  
Carmen Scieuzo ◽  
Sabino Aurelio Bufo ◽  
...  

Abstract Prothoracicotropic hormone (PTTH) is a neuropeptide that triggers a cascade of events within the prothoracic gland (PG) cells, leading to the activation of all the crucial enzymes involved in ecdysone biosynthesis, the main insect steroid hormone. Studies concerning ecdysteroidogenesis predicted PTTH action using brain extract (BE), consisting in a complex mixture in which some components positively or negatively interfere with PTTH-stimulated ecdysteroidogenesis. Consequently, the integration of these opposing factors in steroidogenic tissues leads to a complex secretory pattern. A recombinant form of prothoracicotropic hormone (rPTTH) from the tobacco budworm Heliothis virescens (F.) (Lepidoptera: Noctuidae) was expressed and purified to perform in vitro tests in a standard and repeatable manner. A characterization of rPTTH primary and secondary structures was performed. The ability of rPTTH and H. virescens BE to stimulate ecdysteroidogenesis was investigated on the third day of fifth larval stage. rPTTH activity was compared with the BE mixture by enzyme immunoassay and western blot, revealing that they equally stimulate the production of significant amount of ecdysone, through a transduction cascade that includes the TOR pathway, by the phosphorylation of 4E binding protein (4E-BP) and S6 kinase (S6K), the main targets of TOR protein. The results of these experiments suggest the importance of obtaining a functional pure hormone to perform further studies, not depending on the crude brain extract, composed by different elements and susceptible to different uncontrollable variables.

2003 ◽  
Vol 254-256 ◽  
pp. 319-322 ◽  
Author(s):  
Khiam Aik Khor ◽  
M. Espanol Pons ◽  
Gemma Bertran-Vidal ◽  
Núria Llorca-Isern ◽  
Michel Jeandin ◽  
...  

1986 ◽  
Vol 32 (8) ◽  
pp. 711-717 ◽  
Author(s):  
Yasuo Aizono ◽  
Noboru Matsuo ◽  
Yoshihiro Yoshida ◽  
Gunki Funatsu ◽  
Masaru Funatsu ◽  
...  

2020 ◽  
Vol 21 (11) ◽  
pp. 4152 ◽  
Author(s):  
Enzo Spisni ◽  
Giovannamaria Petrocelli ◽  
Veronica Imbesi ◽  
Renato Spigarelli ◽  
Demetrio Azzinnari ◽  
...  

Essential oils (EOs) are a complex mixture of hydrophobic and volatile compounds synthesized from aromatic plants, most of them commonly used in the human diet. In recent years, many studies have analyzed their antimicrobial, antioxidant, anti-inflammatory, immunomodulatory and anticancer properties in vitro and on experimentally induced animal models of colitis and colorectal cancer. However, there are still few clinical studies aimed to understand their role in the modulation of the intestinal pathophysiology. Many EOs and some of their molecules have demonstrated their efficacy in inhibiting bacterial, fungi and virus replication and in modulating the inflammatory and oxidative processes that take place in experimental colitis. In addition to this, their antitumor activity against colorectal cancer models makes them extremely interesting compounds for the modulation of the pathophysiology of the large bowel. The characterization of these EOs is made difficult by their complexity and by the different compositions present in the same oil having different geographical origins. This review tries to shift the focus from the EOs to their individual compounds, to expand their possible applications in modulating colon pathophysiology.


Sign in / Sign up

Export Citation Format

Share Document